Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23035 | 304 | 28.4 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1701 | 6131 | INTERNATIONAL JOURNAL OF HYPERTHERMIA//ISOLATED LIMB PERFUSION//LONIDAMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LONIDAMINE | Author keyword | 142 | 79% | 30% | 92 |
2 | IONIDAMINE | Author keyword | 4 | 67% | 1% | 4 |
3 | ADVANCED BREAST CANCER CHEMOTHERAPY | Author keyword | 1 | 100% | 1% | 2 |
4 | ANTISPERMATOGENIC DRUGS | Author keyword | 1 | 100% | 1% | 2 |
5 | LONIDAMINE AND BREAST CANCER | Author keyword | 1 | 100% | 1% | 2 |
6 | LONIDAMINE THERAPY | Author keyword | 1 | 100% | 1% | 2 |
7 | MALE PUBERTAL MICE | Author keyword | 1 | 100% | 1% | 2 |
8 | MITOMYCIN C DRUG COMBINATION | Author keyword | 1 | 100% | 1% | 2 |
9 | TOLNIDAMINE | Author keyword | 1 | 100% | 1% | 2 |
10 | EHRLICH TUMOR CELLS | Author keyword | 1 | 30% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LONIDAMINE | 142 | 79% | 30% | 92 | Search LONIDAMINE | Search LONIDAMINE |
2 | IONIDAMINE | 4 | 67% | 1% | 4 | Search IONIDAMINE | Search IONIDAMINE |
3 | ADVANCED BREAST CANCER CHEMOTHERAPY | 1 | 100% | 1% | 2 | Search ADVANCED+BREAST+CANCER+CHEMOTHERAPY | Search ADVANCED+BREAST+CANCER+CHEMOTHERAPY |
4 | ANTISPERMATOGENIC DRUGS | 1 | 100% | 1% | 2 | Search ANTISPERMATOGENIC+DRUGS | Search ANTISPERMATOGENIC+DRUGS |
5 | LONIDAMINE AND BREAST CANCER | 1 | 100% | 1% | 2 | Search LONIDAMINE+AND+BREAST+CANCER | Search LONIDAMINE+AND+BREAST+CANCER |
6 | LONIDAMINE THERAPY | 1 | 100% | 1% | 2 | Search LONIDAMINE+THERAPY | Search LONIDAMINE+THERAPY |
7 | MALE PUBERTAL MICE | 1 | 100% | 1% | 2 | Search MALE+PUBERTAL+MICE | Search MALE+PUBERTAL+MICE |
8 | MITOMYCIN C DRUG COMBINATION | 1 | 100% | 1% | 2 | Search MITOMYCIN+C+DRUG+COMBINATION | Search MITOMYCIN+C+DRUG+COMBINATION |
9 | TOLNIDAMINE | 1 | 100% | 1% | 2 | Search TOLNIDAMINE | Search TOLNIDAMINE |
10 | EHRLICH TUMOR CELLS | 1 | 30% | 1% | 3 | Search EHRLICH+TUMOR+CELLS | Search EHRLICH+TUMOR+CELLS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IONIDAMINE | 31 | 92% | 4% | 12 |
2 | PLUS LONIDAMINE | 14 | 100% | 2% | 7 |
3 | ANTINEOPLASTIC DRUG LONIDAMINE | 6 | 71% | 2% | 5 |
4 | INDAZOLE CARBOXYLIC ACIDS | 3 | 100% | 1% | 3 |
5 | LONIDAMINE | 3 | 18% | 4% | 13 |
6 | AGENT LONIDAMINE | 2 | 50% | 1% | 3 |
7 | 5 BROMO 2 DEOXY URIDINE | 1 | 100% | 1% | 2 |
8 | INVIVO CONTROL | 1 | 100% | 1% | 2 |
9 | DRUG LONIDAMINE | 1 | 50% | 0% | 1 |
10 | GERM CELL MITOCHONDRIA | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors | 2003 | 62 | 48 | 90% |
Pharmacokinetics and metabolism of lonidamine in rats: Evidence of enterohepatic recycling | 1997 | 2 | 12 | 100% |
Recent studies on lonidamine, the lead compound of the antispermatogenic indazol-carboxylic acids | 2002 | 8 | 17 | 71% |
The adenine nucleotide translocator: A new potential chemotherapeutic target | 2003 | 24 | 47 | 19% |
Mitochondrion as a novel target of anticancer chemotherapy | 2000 | 312 | 139 | 5% |
Mitochondria as targets for established and novel anti-cancer agents | 2001 | 47 | 65 | 9% |
Chemotherapy: targeting the mitochondrial cell death pathway | 2002 | 246 | 169 | 3% |
Mitochondria as a target for inducing death of malignant hematopoietic cells | 2003 | 30 | 136 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ASL6 | 1 | 50% | 0.3% | 1 |
2 | EXPTL CHEMOTHER Y | 1 | 50% | 0.3% | 1 |
3 | HUMAN BIOPATHOL HAEMATOL | 1 | 50% | 0.3% | 1 |
4 | PNEUMOONCOL 5 | 1 | 50% | 0.3% | 1 |
5 | SECT RECH CYTOGENET MOL ONCOL | 1 | 50% | 0.3% | 1 |
6 | SPECIAL SPECIES MED | 1 | 50% | 0.3% | 1 |
7 | UNITE MIXTE RECH 147 | 0 | 33% | 0.3% | 1 |
8 | CAECIS | 0 | 25% | 0.3% | 1 |
9 | MED DIPARTIMENTO MED SPERIMENTALE | 0 | 25% | 0.3% | 1 |
10 | PHARMACOL NAT SUBSTANCES GEN PHYSIOL | 0 | 13% | 0.7% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000117862 | DIACEREIN//DIACERHEIN//DIACETYLRHEIN |
2 | 0.0000103800 | PHLIP//TUMOR ACIDITY//TUMOR PH |
3 | 0.0000098131 | WHOLE BODY HYPERTHERMIA//THERMOCHEMOTHERAPY//INTRACELLULAR PLATINUM UPTAKE |
4 | 0.0000088453 | INDAZOLES//2H INDAZOLES//INDAZOLE |
5 | 0.0000082180 | GLUTATHIONE DOXORUBICIN CONJUGATE//RAT HEPATOMA CELL//SIMULTANEOUS IMMOBILIZATION |
6 | 0.0000067587 | WARBURG EFFECT//PKM2//3 BROMOPYRUVATE |
7 | 0.0000060959 | MARY M WOHLFORD MALE CONTRACEPT//ECTOPLASMIC SPECIALIZATION//BLOOD TESTIS BARRIER |
8 | 0.0000049107 | THERMORADIOSENSITIZATION//THERMAL RADIOSENSITIZATION//LONG DURATION MILD HYPERTHERMIA |
9 | 0.0000047777 | AGED RELATED CHANGES//AGEING RAT//HISTOENZYMIC DISTRIBUTION |
10 | 0.0000044251 | HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER |